Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the September issue where our cover feature explores the microbes living in and on our bodies – and what they mean for drug discovery. Upfront asks: can gender bias skew preclinical results? And could a mosaic-based vaccine offer at-risk people more choice when it comes to HIV prevention? Sue Springett highlights the importance of health and safety in the lab, in In My View; and in Business, we speak with Ron Kander and Parviz Shamlou about Jefferson’s Institute for Bioprocessing, and Maeve Magner explains how digital solutions can improve the supply chains of emerging economies. Finally, we Sit Down With Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.